Estrogen decreases neointimal hyperplasia and improves re-endothelialization in pigs.
BACKGROUND
17-Beta-estradiol inhibits smooth muscle cell proliferation and migration and accelerates endothelial cell repair in response to balloon injury. The aim of this study was to determine whether administration of estrogen is associated with decreased neointimal hyperplasia after stenting in the porcine model.


RESULTS
Twenty-two farm female pigs 7 months old were oophorectomized and at the third day normal saline (11 pigs) or 20 mg of estradiol valerate (11 pigs), modified release, were administered intramuscularly. At the 10th day after oophorerectomy, 1 or 2 stainless steel stents were implanted in the right coronary artery in each pig, and at the 17th day, normal saline or 10 mg estradiol valerate, modified release, were administered intramuscularly in the two groups. Pigs were sacrificed 28 days after stent implantation and histomorphometric analysis of the coronary arteries was performed (20 stents from the estrogen and 18 stents from the control groups). In the estrogen group, neointimal proliferation area was 1.42+/-0.55 mm(2), whereas in the control group, 1.96+/-0.89 mm(2) (p=0.02). Area stenosis was 39+/-13% and 49+/-16% in the two groups, respectively (p=0.07). Re-endothelialization was 2.67+/-0.34 and 2.22+/-0.46 in the two groups, respectively (p<0.010). The injury score was similar between the two groups.


CONCLUSIONS
These data suggest that intramuscular administration of estrogen accelerates the endothelial cell repair in response to injury and reduces intimal hyperplasia in the porcine model.
Kyriakides
Zenon S
ZS
Red Cross Hospital, Athens, Greece. zskyr@otenet.gr
Lymberopoulos
Elias
E
Papalois
Apostolos
A
Kyrzopoulos
Stamatis
S
Dafnomili
Vassiliki
V
Sbarouni
Eftihia
E
Kremastinos
Dimitri Th
DT
D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects / Q000473:pathology* / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000503:physiopathology*; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D005260:Female; D006965:Hyperplasia; D007273:Injections, Intramuscular; D010052:Ovariectomy; D012038:Regeneration / Q000187:drug effects*; D015607:Stents / Q000009:adverse effects*; D013552:Swine; D013997:Time Factors; D017539:Tunica Intima / Q000187:drug effects / Q000473:pathology*
D004958:Estradiol